Gender | Age
Item
men older than 18 years old
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Adenocarcinoma of prostate
Item
histologically confirmed diagnosis of adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Disease TNM clinical staging
Item
clinical stage t1c/t2a disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Disease Low Risk | Disease Intermediate Risk | Gleason score | Prostate specific antigen measurement
Item
low and intermediate risk disease defined as either gleason 6 or gleason 7 and psa < 20 ng/ml.
boolean
C0012634 (UMLS CUI [1,1])
C3538919 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C3640764 (UMLS CUI [2,2])
C3203027 (UMLS CUI [3])
C0201544 (UMLS CUI [4])
Prostate volume Ultrasonography | Prostate volume CT | Prostate volume MRI
Item
prostate volume < 60 cc as determined by ultrasound, ct or mri
boolean
C1441416 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C1441416 (UMLS CUI [2,1])
C0040405 (UMLS CUI [2,2])
C1441416 (UMLS CUI [3,1])
C0024485 (UMLS CUI [3,2])
Life Expectancy
Item
life expectancy of more than 10 years
boolean
C0023671 (UMLS CUI [1])
Informed Consent Willing
Item
willing to give informed consent to participate in this clinical trial
boolean
C0021430 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Expanded Prostate Cancer Index Composite Completion
Item
able and willing to complete expanded prostate index composite (epic) questionnaire
boolean
C3810535 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) of 0 - 2.
boolean
C1520224 (UMLS CUI [1])
Informed Consent Competent
Item
give competent informed consent to participate in this trial.
boolean
C0021430 (UMLS CUI [1,1])
C0086035 (UMLS CUI [1,2])
Secondary malignant neoplasm of lymph node | Distant metastasis
Item
documented nodal or distant metastases
boolean
C0686619 (UMLS CUI [1])
C1269798 (UMLS CUI [2])
Radiotherapy to pelvis
Item
previous pelvic radiotherapy
boolean
C1536155 (UMLS CUI [1])
Transurethral Resection of Prostate | Prostatectomy | High-Intensity Focused Ultrasound Ablation
Item
previous trans-urethral resection of prostate, previous prostatectomy or hifu
boolean
C0040771 (UMLS CUI [1])
C0033573 (UMLS CUI [2])
C2348970 (UMLS CUI [3])
Antiandrogen therapy | 5-alpha Reductase Inhibitors allowed
Item
use of androgen deprivation therapy. use of 5-alpha-reductase inhibitors is permitted
boolean
C0279492 (UMLS CUI [1])
C2936788 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
Urinary function Poor International Prostate Symptom Score
Item
poor baseline urinary function defined as international prostate symptom score (ipss) >19
boolean
C0042034 (UMLS CUI [1,1])
C0542537 (UMLS CUI [1,2])
C1998280 (UMLS CUI [1,3])
Medical contraindication Radiotherapy to prostate Radical
Item
contra-indication to radical prostate radiotherapy
boolean
C1301624 (UMLS CUI [1,1])
C0948317 (UMLS CUI [1,2])
C0439807 (UMLS CUI [1,3])
Comorbidity Significant | Patient Inappropriate General Anesthesia
Item
significant medical co-morbidity rendering patient unsuitable for general anaesthetic
boolean
C0009488 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C0002915 (UMLS CUI [2,3])